Loading...
Jushi Holdings Inc.
JUSHF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.51
$0.06(13.93%)
Jushi Holdings Inc. (JUSHF) Financial Performance & Income Statement Overview
Review Jushi Holdings Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-29.19%
↓ 29.19%
Operating Income Growth
39.37%
↑ 39.37%
Net Income Growth
44.49%
↑ 44.49%
Operating Cash Flow Growth
581.64%
↑ 581.64%
Operating Margin
1.90%
↑ 1.90%
Gross Margin
42.17%
↑ 42.17%
Net Profit Margin
-18.54%
↓ 18.54%
ROE
106.07%
↑ 106.07%
ROIC
1.31%
↑ 1.31%
Jushi Holdings Inc. (JUSHF) Income Statement & Financial Overview
Review Jushi Holdings Inc.'s (JUSHF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $65.86M | $61.61M | $64.59M | $65.46M |
| Cost of Revenue | $40.45M | $33.61M | $32.03M | $33.13M |
| Gross Profit | $25.41M | $28.00M | $32.57M | $32.33M |
| Gross Profit Ratio | $0.39 | $0.45 | $0.50 | $0.49 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $18.86M | $19.95M | $19.11M | $21.16M |
| Operating Expenses | $27.25M | $27.82M | $24.16M | $28.21M |
| Total Costs & Expenses | $67.70M | $61.43M | $56.19M | $61.34M |
| Interest Income | $78000.00 | $128000.00 | $247000.00 | $104000.00 |
| Interest Expense | $9.51M | $9.51M | $9.32M | $9.65M |
| Depreciation & Amortization | $7.91M | $7.77M | $7.38M | $9.22M |
| EBITDA | $8.54M | $10.23M | $16.27M | $10.62M |
| EBITDA Ratio | $0.13 | $0.17 | $0.25 | $0.16 |
| Operating Income | -$1.84M | $180000.00 | $8.40M | $4.12M |
| Operating Income Ratio | -$0.03 | $0.003 | $0.13 | $0.06 |
| Other Income/Expenses (Net) | -$7.04M | -$7.23M | -$1.01M | -$12.73M |
| Income Before Tax | -$8.88M | -$7.05M | $7.39M | -$8.61M |
| Income Before Tax Ratio | -$0.13 | -$0.11 | $0.11 | -$0.13 |
| Income Tax Expense | $3.59M | $8.96M | $9.33M | $9.75M |
| Net Income | -$12.47M | -$16.02M | -$1.94M | -$18.36M |
| Net Income Ratio | -$0.19 | -$0.26 | -$0.03 | -$0.28 |
| EPS | -$0.06 | -$0.08 | -$0.01 | -$0.09 |
| Diluted EPS | -$0.06 | -$0.08 | -$0.010 | -$0.09 |
| Weighted Avg Shares Outstanding | $193.80M | $193.80M | $193.80M | $195.13M |
| Weighted Avg Shares Outstanding (Diluted) | $195.14M | $195.14M | $195.14M | $195.13M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan